Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Biopharmaceutical Third Party Logistics (3PL) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global biopharmaceutical third party logistics (3PL) market exhibited moderate growth during 2015-2020. Biopharmaceutical third-party logistics (3PL) refer to the services outsourced by pharmaceutical companies through third-party organizations. It involves receiving small molecule drugs, vaccines, biologics and other medical products into the warehouse, fulfilling orders and handling inventory of the goods through a warehouse management system. 3PL assists pharma and medical institutions in maintaining the logistics for delivering medical therapies, reducing medicine prices by minimizing wasteful overhead expenses, ensuring uninterrupted product supply, improving transportation services and enhancing the overall efficiencies of the organization.

Significant growth in the pharmaceutical industries is one of the key factors creating a positive outlook for the market. Furthermore, the emerging trend of outsourcing logistics by various medical organizations to optimize their distribution network is providing a thrust to the market growth. As the coronavirus disease (COVID-19) continues to spread across the globe, there has been a significant increase in the demand for 3PL logistics to minimize drug supply disruptions and prioritize the availability of critical care drugs. Various technological advancements, such as the launch of warehouse robotics, mobile cloud computing, real-time monitoring and data mining solutions, are acting as other growth-inducing factors. These technologies aid in automating logistics-related processes and minimizing operation complexities, human errors and damages caused to the products in transit. In line with this, Near Field Communication (NFC) and Internet of Thing (IoT)-based cold chain monitoring products are also being used to manage temperature-sensitive pharmaceutical products and get real-time updates and alerts regarding the shipments. Looking forward, IMARC Group expects the global biopharmaceutical third party logistics (3PL) market to grow at a CAGR of around 7% during the forecast period (2021-2026).

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global biopharmaceutical third party logistics (3PL) market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, supply chain and service type.

Breakup by Supply Chain:

  • Cold Chain
  • Non-Cold Chain
     

Breakup by Service Type:

  • Transportation
    • Air Freight
    • Sea Freight
    • Overland
  • Warehousing and Storage
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Agility Logistics, AmerisourceBergen Corporation, DB Schenker (Deutsche Bahn), DHL International GmbH (Deutsche Post), FedEx Corporation, Kerry Logistics Network Limited, Kuehne + Nagel International AG, McKesson Corporation, SF Express Co. Ltd. and United Parcel Service of America Inc.

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Biopharmaceutical Third Party Logistics (3PL) Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Supply Chain
    6.1    Cold Chain
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Non-Cold Chain
        6.2.1 Market Trends
        6.2.2 Market Forecast
7    Market Breakup by Service Type
    7.1   Transportation        
        7.1.1 Market Trends
        7.1.2 Key Types
           7.1.2.1 Air Freight
           7.1.2.2 Sea Freight
           7.1.2.3 Overland
        7.1.3 Market Forecast    
    7.2    Warehousing and Storage
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Others
        7.3.1 Market Trends
        7.3.2 Market Forecast
8    Market Breakup by Region
    8.1    North America
        8.1.1 United States
           8.1.1.1 Market Trends
           8.1.1.2 Market Forecast
        8.1.2 Canada
           8.1.2.1 Market Trends
           8.1.2.2 Market Forecast
    8.2    Asia-Pacific
        8.2.1 China
           8.2.1.1 Market Trends
           8.2.1.2 Market Forecast
        8.2.2 Japan
           8.2.2.1 Market Trends
           8.2.2.2 Market Forecast
        8.2.3 India
           8.2.3.1 Market Trends
           8.2.3.2 Market Forecast
        8.2.4 South Korea
           8.2.4.1 Market Trends
           8.2.4.2 Market Forecast
        8.2.5 Australia
           8.2.5.1 Market Trends
           8.2.5.2 Market Forecast
        8.2.6 Indonesia
           8.2.6.1 Market Trends
           8.2.6.2 Market Forecast
        8.2.7 Others
           8.2.7.1 Market Trends
           8.2.7.2 Market Forecast
    8.3    Europe
        8.3.1 Germany
           8.3.1.1 Market Trends
           8.3.1.2 Market Forecast
        8.3.2 France
           8.3.2.1 Market Trends
           8.3.2.2 Market Forecast
        8.3.3 United Kingdom
           8.3.3.1 Market Trends
           8.3.3.2 Market Forecast
        8.3.4 Italy
           8.3.4.1 Market Trends
           8.3.4.2 Market Forecast
        8.3.5 Spain
           8.3.5.1 Market Trends
           8.3.5.2 Market Forecast
        8.3.6 Russia
           8.3.6.1 Market Trends
           8.3.6.2 Market Forecast
        8.3.7 Others
           8.3.7.1 Market Trends
           8.3.7.2 Market Forecast
    8.4    Latin America
        8.4.1 Brazil
           8.4.1.1 Market Trends
           8.4.1.2 Market Forecast
        8.4.2 Mexico
           8.4.2.1 Market Trends
           8.4.2.2 Market Forecast
        8.4.3 Others
           8.4.3.1 Market Trends
           8.4.3.2 Market Forecast
    8.5    Middle East and Africa
        8.5.1 Market Trends
        8.5.2 Market Breakup by Country
        8.5.3 Market Forecast
9    SWOT Analysis
    9.1    Overview
    9.2    Strengths
    9.3    Weaknesses
    9.4    Opportunities
    9.5    Threats
10    Value Chain Analysis
11    Porters Five Forces Analysis

    11.1    Overview
    11.2    Bargaining Power of Buyers
    11.3    Bargaining Power of Suppliers
    11.4    Degree of Competition
    11.5    Threat of New Entrants
    11.6    Threat of Substitutes
12    Price Analysis
13    Competitive Landscape

    13.1    Market Structure
    13.2    Key Players
    13.3    Profiles of Key Players
        13.3.1    Agility Logistics
           13.3.1.1 Company Overview
           13.3.1.2 Product Portfolio
           13.3.1.3 Financials
        13.3.2    AmerisourceBergen Corporation
           13.3.2.1 Company Overview
           13.3.2.2 Product Portfolio
           13.3.2.3 Financials
           13.3.2.4 SWOT Analysis
        13.3.3    DB Schenker (Deutsche Bahn)
           13.3.3.1 Company Overview
           13.3.3.2 Product Portfolio
        13.3.4    DHL International GmbH (Deutsche Post)
           13.3.4.1 Company Overview
           13.3.4.2 Product Portfolio
        13.3.5    Fedex Corporation
           13.3.5.1 Company Overview
           13.3.5.2 Product Portfolio
           13.3.5.3 Financials
           13.3.5.4 SWOT Analysis
        13.3.6    Kerry Logistics Network Limited
           13.3.6.1 Company Overview
           13.3.6.2 Product Portfolio
           13.3.6.3 Financials
           13.3.6.4 SWOT Analysis
        13.3.7    Kuehne + Nagel International AG
           13.3.7.1 Company Overview
           13.3.7.2 Product Portfolio
           13.3.7.3 Financials
        13.3.8    McKesson Corporation
           13.3.8.1 Company Overview
           13.3.8.2 Product Portfolio
           13.3.8.3 Financials
           13.3.8.4 SWOT Analysis
        13.3.9    SF Express Co. Ltd.
           13.3.9.1 Company Overview
           13.3.9.2 Product Portfolio
        13.3.10    United Parcel Service of America Inc.
           13.3.10.1 Company Overview
           13.3.10.2 Product Portfolio
           13.3.10.3 Financials
           13.3.10.4 SWOT Analysis

List of Figures

Figure 1: Global: Biopharmaceutical Third Party Logistics Market: Major Drivers and Challenges
Figure 2: Global: Biopharmaceutical Third Party Logistics Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Biopharmaceutical Third Party Logistics Market: Breakup by Supply Chain (in %), 2020
Figure 5: Global: Biopharmaceutical Third Party Logistics Market: Breakup by Service Type (in %), 2020
Figure 6: Global: Biopharmaceutical Third Party Logistics Market: Breakup by Region (in %), 2020
Figure 7: Global: Biopharmaceutical Third Party Logistics (Cold Chain) Market: Sales Value (in Million US$), 2015 & 2020
Figure 8: Global: Biopharmaceutical Third Party Logistics (Cold Chain) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 9: Global: Biopharmaceutical Third Party Logistics (Non-Cold Chain) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Global: Biopharmaceutical Third Party Logistics (Non-Cold Chain) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Global: Biopharmaceutical Third Party Logistics (Transportation) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Biopharmaceutical Third Party Logistics (Transportation) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Biopharmaceutical Third Party Logistics (Warehousing and Storage) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Biopharmaceutical Third Party Logistics (Warehousing and Storage) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Biopharmaceutical Third Party Logistics (Other Service Types) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Biopharmaceutical Third Party Logistics (Other Service Types) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: North America: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: North America: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: United States: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: United States: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Canada: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Canada: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Asia-Pacific: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Asia-Pacific: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: China: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: China: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Japan: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Japan: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: India: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: India: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: South Korea: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: South Korea: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Australia: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Australia: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Indonesia: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Indonesia: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: Others: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: Others: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: Europe: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: Europe: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: Germany: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: Germany: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: France: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: France: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: United Kingdom: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: United Kingdom: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: Italy: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: Italy: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: Spain: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: Spain: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: Russia: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: Russia: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: Others: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: Others: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: Latin America: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: Latin America: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: Brazil: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: Brazil: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: Mexico: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: Mexico: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: Others: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: Others: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: Middle East and Africa: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 64: Middle East and Africa: Biopharmaceutical Third Party Logistics Market: Breakup by Country (in %), 2020
Figure 65: Middle East and Africa: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: Global: Biopharmaceutical Third Party Logistics Industry: SWOT Analysis
Figure 67: Global: Biopharmaceutical Third Party Logistics Industry: Value Chain Analysis
Figure 68: Global: Biopharmaceutical Third Party Logistics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Biopharmaceutical Third Party Logistics Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Biopharmaceutical Third Party Logistics Market Forecast: Breakup by Supply Chain (in Million US$), 2021-2026
Table 3: Global: Biopharmaceutical Third Party Logistics Market Forecast: Breakup by Service Type (in Million US$), 2021-2026
Table 4: Global: Biopharmaceutical Third Party Logistics Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 5: Global: Biopharmaceutical Third Party Logistics Market: Competitive Structure
Table 6: Global: Biopharmaceutical Third Party Logistics Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Question Answered in this Report

According to the estimates by IMARC Group, the global biopharmaceutical third-party logistics (3PL) market is expected to witness a CAGR of 7% during 2021-2026.

The increasing adoption of outsourced logistics services by various medical organizations to optimize their distribution network represents one of the key drivers for the global biopharmaceutical third-party logistics (3PL) market.

The rising integration of 3PL services with warehouse robotics, mobile cloud computing, real-time monitoring, and data mining solutions, represents one of the key trends in the global biopharmaceutical third-party logistics (3PL) market.

Sudden outbreak of the COVID-19 pandemic had led to a significant increase in the demand for 3PL logistics to minimize drug supply disruptions and prioritize the availability of critical care drugs.

On the basis of the supply chain, the market has been divided into cold chain and non-cold chain. Among these, non-cold chain represents the largest segment.

On the basis of the service type, the market has been bifurcated into transportation, warehousing and storage, and others. Currently, warehousing and storage holds the majority of the total market share.

Region-wise, the market has been classified into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America, where North America dominates the global market.

The key companies in the global biopharmaceutical third-party logistics (3PL) market are Agility Logistics, AmerisourceBergen Corporation, DB Schenker (Deutsche Bahn), DHL International GmbH (Deutsche Post), FedEx Corporation, Kerry Logistics Network Limited, Kuehne + Nagel International AG, McKesson Corporation, SF Express Co. Ltd., and United Parcel Service of America Inc.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links